Literature DB >> 28079543

A novel anti-HIV immunotherapy to cure HIV.

Ali Ahmad1, Charles R Rinaldo.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28079543      PMCID： PMC7898938          DOI： 10.1097/QAD.0000000000001331

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  31 in total

Review 1.  Role of CD27/CD70 pathway of activation in immunity and tolerance.

Authors:  Julie Denoeud; Muriel Moser
Journal:  J Leukoc Biol       Date:  2010-08-10       Impact factor: 4.962

Review 2.  Dendritic cell based vaccines for HIV infection: the way ahead.

Authors:  Felipe García; Montserrat Plana; Nuria Climent; Agathe León; Jose M Gatell; Teresa Gallart
Journal:  Hum Vaccin Immunother       Date:  2013-08-02       Impact factor: 3.452

3.  CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles.

Authors:  Yew Ann Leong; Yaping Chen; Hong Sheng Ong; Di Wu; Kevin Man; Claire Deleage; Martina Minnich; Benjamin J Meckiff; Yunbo Wei; Zhaohua Hou; Dimitra Zotos; Kevin A Fenix; Anurag Atnerkar; Simon Preston; Jeffrey G Chipman; Greg J Beilman; Cody C Allison; Lei Sun; Peng Wang; Jiawei Xu; Jesse G Toe; Hao K Lu; Yong Tao; Umaimainthan Palendira; Alexander L Dent; Alan L Landay; Marc Pellegrini; Iain Comerford; Shaun R McColl; Timothy W Schacker; Heather M Long; Jacob D Estes; Meinrad Busslinger; Gabrielle T Belz; Sharon R Lewin; Axel Kallies; Di Yu
Journal:  Nat Immunol       Date:  2016-08-03       Impact factor: 25.606

4.  PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells.

Authors:  Ravikumar Muthuswamy; Jan Mueller-Berghaus; Uwe Haberkorn; Todd A Reinhart; Dirk Schadendorf; Pawel Kalinski
Journal:  Blood       Date:  2010-05-24       Impact factor: 22.113

5.  CD40L induces functional tunneling nanotube networks exclusively in dendritic cells programmed by mediators of type 1 immunity.

Authors:  Colleen R Zaccard; Simon C Watkins; Pawel Kalinski; Ronald J Fecek; Aarika L Yates; Russell D Salter; Velpandi Ayyavoo; Charles R Rinaldo; Robbie B Mailliard
Journal:  J Immunol       Date:  2014-12-29       Impact factor: 5.422

Review 6.  TLR3: interferon induction by double-stranded RNA including poly(I:C).

Authors:  Misako Matsumoto; Tsukasa Seya
Journal:  Adv Drug Deliv Rev       Date:  2008-01-02       Impact factor: 15.470

Review 7.  Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.

Authors:  Mark A Hauser; Daniel F Legler
Journal:  J Leukoc Biol       Date:  2016-01-04       Impact factor: 4.962

8.  A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.

Authors:  Beatriz Mothe; Xintao Hu; Anuska Llano; Margherita Rosati; Alex Olvera; Viraj Kulkarni; Antonio Valentin; Candido Alicea; Guy R Pilkington; Niranjan Y Sardesai; Muntsa Rocafort; Manel Crespo; Jorge Carrillo; Andrés Marco; James I Mullins; Lucy Dorrell; Tomáš Hanke; Bonaventura Clotet; George N Pavlakis; Barbara K Felber; Christian Brander
Journal:  J Transl Med       Date:  2015-02-15       Impact factor: 5.531

9.  Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.

Authors:  Kellie N Smith; Robbie B Mailliard; Paolo A Piazza; Will Fischer; Bette T Korber; Ronald J Fecek; Deena Ratner; Phalguni Gupta; James I Mullins; Charles R Rinaldo
Journal:  mBio       Date:  2016-05-31       Impact factor: 7.867

10.  Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.

Authors:  Ahmad R Sedaghat; Robert F Siliciano; Claus O Wilke
Journal:  BMC Infect Dis       Date:  2008-01-02       Impact factor: 3.090
View more
  1 in total

Review 1.  Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill.

Authors:  Jan Kristoff; Charles R Rinaldo; Robbie B Mailliard
Journal:  Viruses       Date:  2019-12-28       Impact factor: 5.818
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.